Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response
2007
Wang, Jingxue | Zhang, Yongmin | Wei, Jing | Zhang, Xiaoping | Zhang, Bei | Zhu, Zhenyuan | Zou, Wei | Wang, Yiqin | Mou, Zhirong | Ni, Bin | Wu, Yuzhang
Dendritic cell-specific intercellular-adhesion-molecule-grabbing non-integrin (DC-SIGN) is a potential target receptor for vaccination purposes. In the present study, we employed Lewis X (Lex) oligosaccharides, which mimic natural ligands, to target ovalbumin (OVA) to human dendritic cells (DCs) via DC-SIGN, to investigate the effect of this DC-SIGN-targeting strategy on the OVA-specific immune response. We demonstrated that Lex oligosaccharides could enhance the OVA-specific immune response as determined by enzyme-linked immunospot assay (ELISPOT), intracellular interferon-γ staining and ⁵¹Cr-release assay. An almost 300-fold lower dose of Lex-OVA induced balanced interferon-γ-secreting cells compared to OVA alone. Furthermore, secretion of interleukin-10, a reported mediator of immune suppression related to DC-SIGN, was not increased by Lex-OVA, either alone or together with sCD40L-stimulated groups. A blocking antibody against DC-SIGN (12507) reduced the numbers of interferon-γ-secreting cells during Lex-OVA stimulation, yet it did not prevent Lex oligosaccharides from promoting the secretion of interleukin-10 that was induced by ultra-pure lipopolysaccharide. These results suggested that the strategy of DC-SIGN targeting mediated by Lex oligosaccharides could promote a T-cell response. This DC-targeting may imply a novel vaccination strategy.
显示更多 [+] 显示较少 [-]